| Unaudited interim condensed consolidated statements of comprehensive loss | 1 | | --- | --- | | Unaudited interim condensed consolidated statements of financial position | 2 | | Unaudited interim condensed consolidated statements of changes in equity | 3 | | Unaudited interim condensed consolidated statements of cash flows | 4 | | Notes to the unaudited interim condensed consolidated financial statements | 5 | | Note 1. General information | 5 | | Note 2. Accounting standards and basis of preparation | 5 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ OR ☐ SHELL COMPANY REPORT PURS ...

Moolec Science SA (NASDAQ:MLEC) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science’s fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima o ...

Company Participants Conference Call Participants This morning, you will hear from Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science, together with Jose Lopez Lecube, Chief Financial Officer and Amit Dhingra, Chief Science Officer. In today's call, we will be referring to a presentation that is available on the company's Investor Relations website. Gaston Paladini As I said before in the press release from this particular topic, Moolec is unlocking the power of plants by leveraging s ...

Moolec Science (NASDAQ:MLEC) stock is taking off on Monday after the company got approval from the Food and Drug Administration (FDA) for its plant-grown animal proteins. According to a press release from the company, this covers its genetically engineered soybean that accumulates animal proteins. The FDA’s Department of Agriculture ruled that the genetically engineered soybean is unlikely to pose an increased plant pest risk compared to normal soybeans.With this the company can continue to development of P ...

The exchange of shares related to the capital Reorganization contemplated by the business combination agreement, explained in Note 1 of the Group's last annual consolidated financial statements as at and for the year ended June 30, 2023, has been given a retrospective effect in the share capital of the statement of changes in equity. Note 6. Intangible Assets (i) The depreciation charge is included in Administrative expenses and Cost of sales (see notes 19 and 20). Note 8. Other receivables Non-current | -- ...

Exhibit 99 Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three month period ended September 30, 2023 and 2022. 1 Moolec Science SA Unaudited interim condensed consolidated Financial Statements as of September 30, 2023 and June 30, 2023, and for the three months ended September 30, 2023 and 2022 | Contents | | --- | | Unaudited interim condensed consolidated statements of comprehensive loss | 3 | | --- | --- | | Unaudited interim condens ...

Moolec announced today's first quarter fiscal year 2024 business highlights yesterday after market closed. The document is now available on the company's Investor Relations website at ir.moolecscience.com. This morning, you will hear from Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science, together with Amit Dhingra, Chief Science Officer; and Jose Lopez Lecube, Chief Financial Officer. Now I would like to turn the call over to Moolec's CEO to comment on our business and recent develo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ OR ☐ SHELL COMPANY REPORT PURS ...

Exhibit 99.1 Unaudited interim condensed consolidated financial statements as of March 31, 2023 and June 30, 2022, and for the three and nine-month periods ended March 31, 2023 and 2022. 1 Moolec Science S.A. Unaudited interim condensed consolidated financial statements as of March 31, 2023 and June 30, 2022, and for the three and nine- months periods ended March 31, 2023 and 2022 Table of Contents | Unaudited interim condensed consolidated statements of operations | 3 | | --- | --- | | Unaudited interim co ...